Asthma and lower airway diseaseTraffic-related air pollution exposure is associated with allergic sensitization, asthma, and poor lung function in middle age
Section snippets
Study population
The study sample consisted of participants in TAHS. The design of this study has been previously described.12 Subjects included in this analysis were adults who participated in the TAHS proband 2002 laboratory study. Briefly, TAHS started in 1968 by recruiting 8583 Tasmanian children aged 7 years. Participants of the baseline survey were known as “probands.” At the baseline survey, parents of the children completed a respiratory health questionnaire and probands underwent clinical examination
Results
The mean age of the cohort at participation was 44.8 ± 1 years and 49% were men (Table I). More than half (55.8%) of the cohort was sensitized to at least 1 of the aeroallergens tested. Sensitization to house dust mite (HDM) was the most prevalent type of allergic sensitization (41.3%), followed by perennial rye grass (32.0%) and mixed grasses (30.7%). The prevalence of current asthma and wheeze was 23.6% and 28.5%, respectively. Study characteristics of the participants without a geocoded
Discussion
Our study provides evidence that current TRAP exposure is associated with an increased risk of allergic sensitization, asthma, and wheeze, and some measures of lung function in adults. The majority of our findings are consistent for both the measures related to TRAP exposure we assessed: annual mean NO2 estimated by a satellite-based LUR model and living less than 200 m from a major road. The mean annual NO2 exposure in our study is very low compared with that in other TRAP exposure studies,
References (41)
- et al.
Environment and asthma in adults
La Presse Médicale
(2013) - et al.
Outdoor air pollution and asthma
Lancet
(2014) - et al.
Oxidative properties of ambient PM2.5 and elemental composition: heterogeneous associations in 19 European cities
Atmos Environ
(2009) - et al.
Oxidative stress and antioxidant defense
World Allergy Organ J
(2012) - et al.
Functional polymorphism of detoxification gene NQO1 predicts intensity of empirical treatment of childhood asthma
Mutat Res
(2009) - et al.
Tracing 8,600 participants 36 years after recruitment at age seven for the Tasmanian Asthma Study
Aust Nz J Public Health
(2006) - et al.
A national satellite-based land-use regression model for air pollution exposure assessment in Australia
Environ Res
(2014) - et al.
Correlation of nitrogen dioxide with other traffic pollutants near a major expressway
Atmos Environ
(2008) - et al.
Urban background particulate matter and allergic sensitization in adults of ECRHS II
Int J Hyg Environ Health
(2007) - et al.
Traffic at residential address, respiratory health, and atopy in adults: the National German Health Survey 1998
Environ Res
(2005)
Role of GSTM1 in resistance to lung inflammation
Free Radic Biol Med
Long-term exposure to air pollution and the incidence of asthma: meta-analysis of cohort studies
Air Qual Atmos Health
The influence of childhood traffic-related air pollution exposure on asthma, allergy and sensitization: a systematic review and a meta-analysis of birth cohort studies
Allergy
NO2-induced generation of extracellular reactive oxygen is mediated by epithelial lining layer antioxidants
Am J Physiol
Air pollution and allergic diseases
Curr Opin Pediatr
Ozone, NO, and NO2: oxidant air pollutants and more
Environ Health Perspect
Interactive effects of antioxidant genes and air pollution on respiratory function and airway disease: a HuGE review
Am J Epidemiol
Assessing the feasibility of a national road classification: report to ICSM on national road classification developments
Near-roadway air quality: synthesizing the findings from real-world data
Environ Sci Technol
Diagnostic procedures in allergy, I: allergy skin testing
Ann Allergy
Cited by (0)
This study was supported by the Centre for Air Quality and Health Research and Evaluation (CAR), a National Health & Medical Research Council Centre of Research Excellence, Australia.
Disclosure of potential conflict of interest: L. D. Knibbs has received research support from the National Health and Medical Research Council (NHMRC; grant no. APP1036620). A. J. Lowe has received research support from the NHMRC and other philanthropic organizations. G. B. Marks has received research support from the NHMRC of Australia, AstraZeneca, and GlaxoSmithKline and was on the Novartis Pharmaceutical COPD Advisory Board. M. J. Abramson has received research support from the NHMRC, Pfizer, and Boehringer Ingelheim; has received consultancy fees from AstraZeneca; and has received travel support from Boehringer Ingelheim and Sanofi. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally as senior authors.